Metoclopramide Recall

June 02, 2025

The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.

On May 23, 2025, Teva Pharmaceuticals USA recalled one lot of metoclopramide 10mg tablets to the consumer level. The recall was initiated because a single tablet of Torsemide 20mg was found in three bottles of the affected lot. Metoclopramide stimulates movement in the upper gastrointestinal tract to treat nausea, vomiting, gastroparesis, and gastroesophageal reflux disease (GERD). Torsemide is a loop diuretic used to treat fluid retention and high blood pressure. Since patients are at increased risk for unintended side effects outside of the metoclopramide safety profile, this recall is being conducted at the consumer level. For details on the recall, see here.


Last updated: June 02, 2025

The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.